Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ A Noto, C De Vitis, ME Pisanu, G Roscilli, G Ricci, A Catizone, ... Oncogene 36 (32), 4573-4584, 2017 | 174 | 2017 |
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells A Noto, S Raffa, C De Vitis, G Roscilli, D Malpicci, P Coluccia, A Di Napoli, ... Cell death & disease 4 (12), e947-e947, 2013 | 158 | 2013 |
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells ME Pisanu, A Noto, C De Vitis, S Morrone, G Scognamiglio, G Botti, ... Cancer letters 406, 93-104, 2017 | 116 | 2017 |
Metabolic features of cancer stem cells: the emerging role of lipid metabolism R Mancini, A Noto, ME Pisanu, C De Vitis, M Maugeri-Saccà, G Ciliberto Oncogene 37 (18), 2367-2378, 2018 | 115 | 2018 |
Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes M D’ascanio, M Innammorato, L Pasquariello, D Pizzirusso, G Guerrieri, ... BMC geriatrics 21, 1-10, 2021 | 90 | 2021 |
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies L Fattore, E Marra, ME Pisanu, A Noto, C de Vitis, F Belleudi, L Aurisicchio, ... Journal of translational medicine 11, 1-11, 2013 | 78 | 2013 |
Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment R Mancini, E Giarnieri, C De Vitis, D Malanga, G Roscilli, A Noto, E Marra, ... PloS one 6 (7), e21320, 2011 | 77 | 2011 |
SCD1, autophagy and cancer: implications for therapy F Ascenzi, C De Vitis, M Maugeri-Saccà, C Napoli, G Ciliberto, R Mancini Journal of Experimental & Clinical Cancer Research 40 (1), 265, 2021 | 71 | 2021 |
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma ME Pisanu, M Maugeri-Saccà, L Fattore, S Bruschini, C De Vitis, E Tabbì, ... Journal of Experimental & Clinical Cancer Research 37, 1-17, 2018 | 70 | 2018 |
Lung cancer stem cell lose their stemness default state after exposure to microgravity ME Pisanu, A Noto, C De Vitis, MG Masiello, P Coluccia, S Proietti, ... BioMed research international 2014, 2014 | 65 | 2014 |
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 E Vescarelli, G Gerini, F Megiorni, E Anastasiadou, P Pontecorvi, L Solito, ... Journal of Experimental & Clinical Cancer Research 39, 1-15, 2020 | 63 | 2020 |
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity G Roscilli, C De Vitis, FF Ferrara, A Noto, E Cherubini, A Ricci, S Mariotta, ... Journal of translational medicine 14, 1-14, 2016 | 59 | 2016 |
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients A Ricci, A Pagliuca, M D’Ascanio, M Innammorato, C De Vitis, R Mancini, ... Respiratory research 22, 1-8, 2021 | 52 | 2021 |
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells D Malanga, C De Marco, I Guerriero, F Colelli, N Rinaldo, M Scrima, ... Oncotarget 6 (40), 42667, 2015 | 51 | 2015 |
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients G Roscilli, M Cappelletti, C De Vitis, G Ciliberto, A Di Napoli, L Ruco, ... Journal of translational medicine 12, 1-6, 2014 | 41 | 2014 |
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer A Noto, C De Vitis, G Roscilli, L Fattore, D Malpicci, E Marra, L Luberto, ... Oncotarget 4 (8), 1253, 2013 | 40 | 2013 |
EMT markers in lung adenocarcinoma pleural effusion spheroid cells E Giarnieri, C De Vitis, A Noto, G Roscilli, G Salerno, S Mariotta, A Ricci, ... Journal of Cellular Physiology 228 (8), 1720-1726, 2013 | 40 | 2013 |
Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors L Aurisicchio, E Marra, L Luberto, F Carlomosti, C De Vitis, A Noto, ... Journal of cellular physiology 227 (10), 3381-3388, 2012 | 40 | 2012 |
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung A Ricci*, C De Vitis*, A Noto*, L Fattore, S Mariotta, E Cherubini, G Roscilli, ... Cell cycle 12 (11), 1696-1703, 2013 | 39 | 2013 |
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma L Fattore, D Malpicci, E Marra, F Belleudi, A Noto, C De Vitis, ME Pisanu, ... Oncotarget 6 (28), 24823, 2015 | 33 | 2015 |